Navigation Links
Ardea Biosciences Presents Inflammation Program Data for Arthritis and Gout at 2008 Annual European Congress of Rheumatology
Date:6/11/2008

- RDEA119 Produced Significant Beneficial Effect in Animal Models of

Arthritis -

- RDEA594 Shows Promise as an Effective Treatment for Gout -

SAN DIEGO, June 11 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA) today announced that data will be presented on the Company's lead mitogen-activated ERK kinase (MEK) inhibitor, RDEA119, demonstrating its potent activity in animal models of arthritis. In addition, the Company will present data on the mechanism of action for RDEA806 and RDEA594 in the area of gout. These data will be presented tomorrow at the 2008 Annual European Congress of Rheumatology Organized by the European League Against Rheumatism (EULAR) in Paris, France.

The extracellular signal-regulated kinase (ERK) pathway plays a critical role in the control of cellular activation, proliferation and the production of inflammatory mediators. Suppression of the ERK pathway by inhibitors of MEK1/2 represents a potential therapeutic approach for treating chronic inflammatory diseases such as rheumatoid arthritis. RDEA119 is a novel selective MEK1/2 inhibitor that was shown to produce a significant beneficial effect in three different animal models of arthritis:

-- Significantly reduced paw swelling in a dose-dependent manner in the

carrageenan-induced paw edema model in rats;

-- Virtually complete reduction in ankle swelling in the adjuvant-induced

arthritis model in rats;

-- Reduced arthritic scores by up to 82% in the collagen antibody-induced

arthritis model in mice.

"We are making excellent progress in all of our inflammation programs. To support the development of RDEA119 in inflammatory diseases, we a
'/>"/>

SOURCE Ardea Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Ardea Biosciences to Present Data on Lead MEK Inhibitor, RDEA119, at Digestive Disease Week 2008
2. Ardea Presents Preclinical Data on Novel Next Generation Non-Nucleoside Reverse Transcriptase Inhibitors Demonstrating Potent Anti-HIV Activity Against Resistant Viruses
3. Ardea to Present Data on HIV Non-Nucleoside Reverse Transcriptase Inhibitor and Two MEK Inhibitors at Upcoming Medical Conferences
4. Ardea to Present at Cowen and Companys 28th Annual Health Care Conference
5. Ardea Biosciences to Move Headquarters and R&D Laboratories to San Diego
6. Ardea Biosciences Establishes Scientific Advisory Board for Inflammation Program
7. Ardea Biosciences to Present at Roth Capital Partners 20th Annual OC Growth Stock Conference
8. Ardea Biosciences Establishes Scientific Advisory Board for HIV Program
9. Ardea Biosciences to Present Preclinical Data on Three HIV Non-Nucleoside Reverse Transcriptase Inhibitors During 15th Annual Conference on Retroviruses and Opportunistic Infections
10. Ardea Biosciences Announces $40 Million Private Placement
11. Ardea Biosciences to Participate in RBC Capital Markets 2007 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Jacobs Automotive, a group of car dealerships headquartered in ... Blood Center and offering free oil change coupons for participation ... Jan. 18 at the Bill Jacobs Cadillac and Chevrolet location ... http://photos.prnewswire.com/prnh/20140115/MN46637 )  The Bill Jacobs Auto annual ...
(Date:1/15/2014)... IL (PRWEB) January 15, 2014 Look ... find hard-working items for the lab, from fluid handling ... Guaranteed-in-Stock (GIS)—ready to ship when you order. , ... Peristaltic Pumps , from the L/S® model for precise ...
(Date:1/15/2014)... ­ RedBrick Health , a fast-growing leader in ... that EmblemHealth , the New York ... providing the RedBrick Compass health assessment, combined with the ... its members. EmblemHealth is among the first health plans ...
(Date:1/15/2014)... 2014 More than 5 million Americans ... in 3 seniors will die with Alzheimer’s or another ... figures have shocked many Americans into looking for ways ... these tragic age-related cognitive disorders. Jonathan Weisman, president of ...
Breaking Biology Technology:Join the Bill Jacobs Auto blood drive and receive a free oil change 2Cole-Parmer Begins 2014 with the Release of Preferred Solutions 2EmblemHealth Selects RedBrick Health to Power its Next-Generation Health Engagement and Behavior Change System 2EmblemHealth Selects RedBrick Health to Power its Next-Generation Health Engagement and Behavior Change System 3Biohack Pure Offers 5 Tips for Increasing Memory in 2014 2
... , , , ... , 2Q09 Corporate Highlights: , ... of Qutenza for treatment of peripheral neuropathic pain in non-diabetic adults, either alone ... Entered exclusive agreement with Astellas Pharma Europe Ltd. (Astellas) for commercialization of ...
... , , Honorees for ... be recognized at Sept. 30 gala ceremony , ... Galien USA will recognize innovative biopharmaceutical drugs and medical technologies that ... at a gala event on September 30. Candidates for the 2009 ...
... ALBANY, Ore., Aug. 6 Synthetech, Inc. (OTC Bulletin Board: ... 2010, which ended June 30, 2009. Revenue for the quarter ... million in the first quarter of fiscal 2009. Operating income ... of $314,000 for the same period last year. Net income ...
Cached Biology Technology:NeurogesX Reports Second Quarter 2009 Results 2NeurogesX Reports Second Quarter 2009 Results 3NeurogesX Reports Second Quarter 2009 Results 4NeurogesX Reports Second Quarter 2009 Results 5NeurogesX Reports Second Quarter 2009 Results 6NeurogesX Reports Second Quarter 2009 Results 7NeurogesX Reports Second Quarter 2009 Results 8NeurogesX Reports Second Quarter 2009 Results 9NeurogesX Reports Second Quarter 2009 Results 10NeurogesX Reports Second Quarter 2009 Results 11NeurogesX Reports Second Quarter 2009 Results 12Prix Galien USA Announces 2009 Final Candidates 2Synthetech Reports First Quarter Fiscal 2010 Results 2Synthetech Reports First Quarter Fiscal 2010 Results 3Synthetech Reports First Quarter Fiscal 2010 Results 4Synthetech Reports First Quarter Fiscal 2010 Results 5Synthetech Reports First Quarter Fiscal 2010 Results 6
(Date:4/18/2014)... that sprout as soon as they,re planted may be good ... more careful. In the wild, a plant whose seeds sprouted ... disaster. More than just an insurance policy against late frosts ... has long-term advantages too: Plants whose seeds put off ... species, finds in a team of researchers working at the ...
(Date:4/18/2014)... of researchers led by a University of California, Riverside ... $7.5 million Department of Defense grant to uncover fundamental ... for the predictable design of light-weight, tough and strong ... from plants and animals, including the mantis shrimp, toucan ... have constructed over millions of years and coming up ...
(Date:4/17/2014)... A drug under clinical trials to treat tuberculosis ... drugs that act against various bacteria, fungal infections and ... University of Illinois chemists and collaborators. , Led by ... determined the different ways the drug SQ109 attacks the ... target other pathogens from yeast to malaria and ...
Breaking Biology News(10 mins):Plants with dormant seeds give rise to more species 2Mantis shrimp, toucan and trilobite, oh my 2Mantis shrimp, toucan and trilobite, oh my 3Multitarget TB drug could treat other diseases, evade resistance 2
... will develop and coordinate a strategic federal research ... breast cancer. The 19-member Interagency Breast Cancer and ... the National Institute of Environmental Health Sciences (NIEHS), ... to review all breast cancer research efforts conducted ...
... for Age Research have successfully used human induced pluripotent ... Disease (PD). The research, which validates a scalable ... be used to manufacture the type of neurons needed ... the use of iPSC,s in various biomedical applications. Results ...
... package developed by a professor at the Virginia Bioinformatics ... understand the workings of biochemical networks now features an ... benefits to its users. In development for over ... collaboration between VBI Professor Pedro Mendes, research groups at ...
Cached Biology News:New breast cancer committee to establish federal research agenda 2New breast cancer committee to establish federal research agenda 3Scientists successfully use human induced pluripotent stem cells to treat Parkinson's in rodents 2Systems biology software package developed at VBI is now open source for all users 2
... Our Accumix standard is a new ... mode electrospray ionization mass spectrometry. Accumix ... broad mass range coverage for both tuning ... LCQ- and LTQ-MS) and Fourier transform mass ...
Goat Anti-Horse IgG(T) Antibody, Unconjugated...
Identify and characterize Phosphoinositide (PI(3,4,5)P3) binding...
Mouse polyclonal antibody to MCFD2 - multiple coagulation factor deficiency 2...
Biology Products: